Rationale, design, demographics and baseline characteristics of the randomized, controlled, Phase 2b SAPPHIRE study of verinurad plus allopurinol in patients with chronic kidney disease and hyperuricaemia Breadcrumbs UL Home Research Year of Publication 2022 Journal Nephrology Dialysis Transplantation DOI 10.1093/ndt/gfab237